Maki Kanzawa

Kobe City Nishi-Kobe Medical Center

Papers

1

Total Citations

1

H-Index

1

About

Maki Kanzawa is a clinician-researcher at the forefront of radiation oncology and prostate cancer management, with a focused expertise in the complications and innovations surrounding hydrogel spacer use during radiotherapy. Her most cited work, a 2025 case report, documents the first successful management of a hydrogel spacer infection through radical prostatectomy—a rare but critical complication. This contribution provides a definitive surgical pathway for abscess control, offering a vital reference for oncologists and urologists navigating spacer-related adverse events. While her citation count is nascent, the paper's immediate relevance to patient safety and procedural refinement signals its growing influence. Kanzawa’s research bridges the gap between radiation technique and surgical salvage, underscoring her commitment to optimizing treatment outcomes and minimizing morbidity. Her work is particularly valuable for trainees and specialists seeking evidence-based solutions to uncommon but serious radiotherapy complications, positioning her as a rising voice in the intersection of radiation oncology and urologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Hydrogel spacer infection during prostate cancer radiotherapy: a case report of successful abscess management through radical prostatectomy
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Kobe City Nishi-Kobe Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago